カテゴリー： QYResearch, 世界

世界の更年期血管運動症状治療市場 2019年

【英語タイトル】Global Vasomotor Symptoms of Menopause Treatment Market Professional Survey Report 2019

・商品コード：DATA909X17296
・発行会社（調査会社）：QYResearch
・発行日：2019年11月22日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

※本調査レポートは、更年期血管運動症状治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エステトロール、フェゾリンタント、FP-101、HBN-2、その他に、用途別には、病院、ホームケア、クリニックにセグメント区分し、更年期血管運動症状治療の世界市場を分析しました。

・エグゼクティブ・サマリー
・更年期血管運動症状治療の世界市場概要
・更年期血管運動症状治療の製造コスト構成分析
・更年期血管運動症状治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・更年期血管運動症状治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・更年期血管運動症状治療のセグメント分析（種類別）
（エステトロール、フェゾリンタント、FP-101、HBN-2、その他）
・更年期血管運動症状治療のセグメント分析（用途別）
（病院、ホームケア、クリニック）
・更年期血管運動症状治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Amgen Inc.、EndoCeutics, Inc.、Euroscreen S.A.、MenoGeniX, Inc.、Mithra Pharmaceuticals S.A.、Pherin Pharmaceuticals, Inc.、Pivot Pharmaceuticals Inc、Radius Health, Inc.、TherapeuticsMD, Inc.、）
・更年期血管運動症状治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Vasomotor Symptoms of Menopause Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Vasomotor Symptoms of Menopause Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Vasomotor Symptoms of Menopause Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Vasomotor Symptoms of Menopause Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Vasomotor Symptoms of Menopause Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen Inc.
EndoCeutics, Inc.
Euroscreen S.A.
MenoGeniX, Inc.
Mithra Pharmaceuticals S.A.
Pherin Pharmaceuticals, Inc.
Pivot Pharmaceuticals Inc
Radius Health, Inc.
TherapeuticsMD, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Estetrol
Fezolinetant
FP-101
HBN-2
Others

Segment by Application
Hospital
Homecare
Clinic

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Vasomotor Symptoms of Menopause Treatment
1.1 Definition of Vasomotor Symptoms of Menopause Treatment
1.2 Vasomotor Symptoms of Menopause Treatment Segment by Type
1.2.1 Global Vasomotor Symptoms of Menopause Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Estetrol
1.2.3 Fezolinetant
1.2.4 FP-101
1.2.5 HBN-2
1.2.6 Others
1.3 Vasomotor Symptoms of Menopause Treatment Segment by Applications
1.3.1 Global Vasomotor Symptoms of Menopause Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Clinic
1.4 Global Vasomotor Symptoms of Menopause Treatment Overall Market
1.4.1 Global Vasomotor Symptoms of Menopause Treatment Revenue (2014-2025)
1.4.2 Global Vasomotor Symptoms of Menopause Treatment Production (2014-2025)
1.4.3 North America Vasomotor Symptoms of Menopause Treatment Status and Prospect (2014-2025)
1.4.4 Europe Vasomotor Symptoms of Menopause Treatment Status and Prospect (2014-2025)
1.4.5 China Vasomotor Symptoms of Menopause Treatment Status and Prospect (2014-2025)
1.4.6 Japan Vasomotor Symptoms of Menopause Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Vasomotor Symptoms of Menopause Treatment Status and Prospect (2014-2025)
1.4.8 India Vasomotor Symptoms of Menopause Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Vasomotor Symptoms of Menopause Treatment
2.3 Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment
2.4 Industry Chain Structure of Vasomotor Symptoms of Menopause Treatment

3 Development and Manufacturing Plants Analysis of Vasomotor Symptoms of Menopause Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Vasomotor Symptoms of Menopause Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Vasomotor Symptoms of Menopause Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Vasomotor Symptoms of Menopause Treatment Production and Capacity Analysis
4.2 Vasomotor Symptoms of Menopause Treatment Revenue Analysis
4.3 Vasomotor Symptoms of Menopause Treatment Price Analysis
4.4 Market Concentration Degree

5 Vasomotor Symptoms of Menopause Treatment Regional Market Analysis
5.1 Vasomotor Symptoms of Menopause Treatment Production by Regions
5.1.1 Global Vasomotor Symptoms of Menopause Treatment Production by Regions
5.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue by Regions
5.2 Vasomotor Symptoms of Menopause Treatment Consumption by Regions
5.3 North America Vasomotor Symptoms of Menopause Treatment Market Analysis
5.3.1 North America Vasomotor Symptoms of Menopause Treatment Production
5.3.2 North America Vasomotor Symptoms of Menopause Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Vasomotor Symptoms of Menopause Treatment Import and Export
5.4 Europe Vasomotor Symptoms of Menopause Treatment Market Analysis
5.4.1 Europe Vasomotor Symptoms of Menopause Treatment Production
5.4.2 Europe Vasomotor Symptoms of Menopause Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Vasomotor Symptoms of Menopause Treatment Import and Export
5.5 China Vasomotor Symptoms of Menopause Treatment Market Analysis
5.5.1 China Vasomotor Symptoms of Menopause Treatment Production
5.5.2 China Vasomotor Symptoms of Menopause Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Vasomotor Symptoms of Menopause Treatment Import and Export
5.6 Japan Vasomotor Symptoms of Menopause Treatment Market Analysis
5.6.1 Japan Vasomotor Symptoms of Menopause Treatment Production
5.6.2 Japan Vasomotor Symptoms of Menopause Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Vasomotor Symptoms of Menopause Treatment Import and Export
5.7 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Analysis
5.7.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Production
5.7.2 Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Vasomotor Symptoms of Menopause Treatment Import and Export
5.8 India Vasomotor Symptoms of Menopause Treatment Market Analysis
5.8.1 India Vasomotor Symptoms of Menopause Treatment Production
5.8.2 India Vasomotor Symptoms of Menopause Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Vasomotor Symptoms of Menopause Treatment Import and Export

6 Vasomotor Symptoms of Menopause Treatment Segment Market Analysis (by Type)
6.1 Global Vasomotor Symptoms of Menopause Treatment Production by Type
6.2 Global Vasomotor Symptoms of Menopause Treatment Revenue by Type
6.3 Vasomotor Symptoms of Menopause Treatment Price by Type

7 Vasomotor Symptoms of Menopause Treatment Segment Market Analysis (by Application)
7.1 Global Vasomotor Symptoms of Menopause Treatment Consumption by Application
7.2 Global Vasomotor Symptoms of Menopause Treatment Consumption Market Share by Application (2014-2019)

8 Vasomotor Symptoms of Menopause Treatment Major Manufacturers Analysis
8.1 Amgen Inc.
8.1.1 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.1.2 Amgen Inc. Product Introduction, Application and Specification
8.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 EndoCeutics, Inc.
8.2.1 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.2.2 EndoCeutics, Inc. Product Introduction, Application and Specification
8.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Euroscreen S.A.
8.3.1 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.3.2 Euroscreen S.A. Product Introduction, Application and Specification
8.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 MenoGeniX, Inc.
8.4.1 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.4.2 MenoGeniX, Inc. Product Introduction, Application and Specification
8.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Mithra Pharmaceuticals S.A.
8.5.1 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.5.2 Mithra Pharmaceuticals S.A. Product Introduction, Application and Specification
8.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Pherin Pharmaceuticals, Inc.
8.6.1 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.6.2 Pherin Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pivot Pharmaceuticals Inc
8.7.1 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.7.2 Pivot Pharmaceuticals Inc Product Introduction, Application and Specification
8.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Radius Health, Inc.
8.8.1 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.8.2 Radius Health, Inc. Product Introduction, Application and Specification
8.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 TherapeuticsMD, Inc.
8.9.1 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
8.9.2 TherapeuticsMD, Inc. Product Introduction, Application and Specification
8.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Vasomotor Symptoms of Menopause Treatment Market
9.1 Global Vasomotor Symptoms of Menopause Treatment Market Trend Analysis
9.1.1 Global Vasomotor Symptoms of Menopause Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Vasomotor Symptoms of Menopause Treatment Regional Market Trend
9.2.1 North America Vasomotor Symptoms of Menopause Treatment Forecast 2019-2025
9.2.2 Europe Vasomotor Symptoms of Menopause Treatment Forecast 2019-2025
9.2.3 China Vasomotor Symptoms of Menopause Treatment Forecast 2019-2025
9.2.4 Japan Vasomotor Symptoms of Menopause Treatment Forecast 2019-2025
9.2.5 Southeast Asia Vasomotor Symptoms of Menopause Treatment Forecast 2019-2025
9.2.6 India Vasomotor Symptoms of Menopause Treatment Forecast 2019-2025
9.3 Vasomotor Symptoms of Menopause Treatment Market Trend (Product Type)
9.4 Vasomotor Symptoms of Menopause Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Vasomotor Symptoms of Menopause Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Vasomotor Symptoms of Menopause Treatment
Table Global Vasomotor Symptoms of Menopause Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Vasomotor Symptoms of Menopause Treatment Production Market Share by Types in 2018
Figure Estetrol Product Picture
Figure Fezolinetant Product Picture
Figure FP-101 Product Picture
Figure HBN-2 Product Picture
Figure Others Product Picture
Table Global Vasomotor Symptoms of Menopause Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Market Share by Applications in 2018
Figure Hospital
Figure Homecare
Figure Clinic
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) (2014-2025)
Figure Global Vasomotor Symptoms of Menopause Treatment Production (K Pcs) (2014-2025)
Figure North America Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) (2014-2025)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) (2014-2025)
Figure China Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) (2014-2025)
Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) (2014-2025)
Figure India Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) (2014-2025)
Table Vasomotor Symptoms of Menopause Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Vasomotor Symptoms of Menopause Treatment in 2018
Figure Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment
Figure Industry Chain Structure of Vasomotor Symptoms of Menopause Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Vasomotor Symptoms of Menopause Treatment Manufacturing Plants Distribution
Table Vasomotor Symptoms of Menopause Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Vasomotor Symptoms of Menopause Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Vasomotor Symptoms of Menopause Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Vasomotor Symptoms of Menopause Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Vasomotor Symptoms of Menopause Treatment Production Share by Manufacturers in 2018
Table Vasomotor Symptoms of Menopause Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Vasomotor Symptoms of Menopause Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Vasomotor Symptoms of Menopause Treatment Revenue Share by Manufacturers in 2018
Table Vasomotor Symptoms of Menopause Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Vasomotor Symptoms of Menopause Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Vasomotor Symptoms of Menopause Treatment Production Market Share by Regions 2014-2019
Figure Global Vasomotor Symptoms of Menopause Treatment Production Market Share by Regions in 2018
Table Global Vasomotor Symptoms of Menopause Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Regions 2014-2019
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Regions in 2018
Table Global Vasomotor Symptoms of Menopause Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Vasomotor Symptoms of Menopause Treatment Consumption Market Share by Regions 2014-2019
Figure North America Vasomotor Symptoms of Menopause Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Vasomotor Symptoms of Menopause Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Vasomotor Symptoms of Menopause Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Vasomotor Symptoms of Menopause Treatment Production, Consumption Import and Export (K Pcs)
Figure China Vasomotor Symptoms of Menopause Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Vasomotor Symptoms of Menopause Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Vasomotor Symptoms of Menopause Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Vasomotor Symptoms of Menopause Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Vasomotor Symptoms of Menopause Treatment Production, Consumption Import and Export (K Pcs)
Figure India Vasomotor Symptoms of Menopause Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Vasomotor Symptoms of Menopause Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Vasomotor Symptoms of Menopause Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Vasomotor Symptoms of Menopause Treatment Market Share by Application (2014-2019)
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Production Sites and Area Served
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Product Introduction, Application and Specification
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Production Growth Rate (2014-2019)
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Production Market Share (2014-2019)
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share (2014-2019)
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Main Business and Markets Served
Figure Global Vasomotor Symptoms of Menopause Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Vasomotor Symptoms of Menopause Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Vasomotor Symptoms of Menopause Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Vasomotor Symptoms of Menopause Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Vasomotor Symptoms of Menopause Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Vasomotor Symptoms of Menopause Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Vasomotor Symptoms of Menopause Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Vasomotor Symptoms of Menopause Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Vasomotor Symptoms of Menopause Treatment by Application (2019-2025)
Table Vasomotor Symptoms of Menopause Treatment Distributors List
Table Vasomotor Symptoms of Menopause Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Amgen Inc.、EndoCeutics, Inc.、Euroscreen S.A.、MenoGeniX, Inc.、Mithra Pharmaceuticals S.A.、Pherin Pharmaceuticals, Inc.、Pivot Pharmaceuticals Inc、Radius Health, Inc.、TherapeuticsMD, Inc.、

★調査レポート[世界の更年期血管運動症状治療市場 2019年] (コード：DATA909X17296)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の更年期血管運動症状治療市場 2019年]についてメールでお問い合わせ

◆関連市場調査レポート◆

世界の早産治療市場 2019年
DATA909X13680 / QYResearch / 2019年11月20日 / ※本調査レポートは、早産治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、プロゲステロン、OBE-022、レトシバン、その他に、用途別には、病院、診療所、その他、にセグメント区分し、早産治療の世界市場を分析しました。・エグゼクティブ・サマリー・早産治療の世界市場概要・早産治療の製造コスト構成分析・早産治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・早産治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・早産治療のセグメント分析（種類別）（プロゲステロン、OBE-022、レトシバン、その他）...The global Premature Labor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Premature Labor Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Premature Labor Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Premature Labor Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

世界の高トリグリセリド血症治療市場 2019年
DATA909X09519 / QYResearch / 2019年11月20日 / ※本調査レポートは、高トリグリセリド血症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BioE-1115、CAT-2003、CDX-085、AEM-2814、ALN-AC3、その他に、用途別には、病院、診療所、その他にセグメント区分し、高トリグリセリド血症治療の世界市場を分析しました。・エグゼクティブ・サマリー・高トリグリセリド血症治療の世界市場概要・高トリグリセリド血症治療の製造コスト構成分析・高トリグリセリド血症治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・高トリグリセリド血症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・高トリグリセリド血症治療のセグメント分析（種類別）（BioE-1115、CAT-2003、CDX-085、AEM-2814、ALN-AC3、その他）...The global Hypertriglyceridemia Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypertriglyceridemia Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypertriglyceridemia Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypertriglyceridemia Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypertriglyceridemia Treatment manufacturing...

世界のウィルソン病治療市場 2019年
DATA909X17798 / QYResearch / 2019年11月22日 / ※本調査レポートは、ウィルソン病治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、D-ペニシラミン、トリエンチン、テトラチオモリブデート、その他に、用途別には、病院、クリニック、その他にセグメント区分し、ウィルソン病治療の世界市場を分析しました。・エグゼクティブ・サマリー・ウィルソン病治療の世界市場概要・ウィルソン病治療の製造コスト構成分析・ウィルソン病治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・ウィルソン病治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・ウィルソン病治療のセグメント分析（種類別）（D-ペニシラミン、トリエンチン、テトラチオモリブデート、その他）...The global Wilson's Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Wilson's Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Wilson's Disease Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Wilson's Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

世界の血管浮腫治療市場 2019年
DATA909X03553 / QYResearch / 2019年11月15日 / ※本調査レポートは、血管浮腫治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗ヒスタミン薬、コルチコステロイド、その他に、用途別には、病院、クリニック、研究機関にセグメント区分し、血管浮腫治療の世界市場を分析しました。・エグゼクティブ・サマリー・血管浮腫治療の世界市場概要・血管浮腫治療の製造コスト構成分析・血管浮腫治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・血管浮腫治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・血管浮腫治療のセグメント分析（種類別）（抗ヒスタミン薬、コルチコステロイド、その他）...The global Angioedema Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Angioedema Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Angioedema Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Angioedema Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Angioedema Treatment manufacturing...

世界のバーキットリンパ腫の治療市場 2019年
DATA909X04887 / QYResearch / 2019年11月15日 / ※本調査レポートは、バーキットリンパ腫の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他に、用途別には、病院、診療所、その他にセグメント区分し、バーキットリンパ腫の治療の世界市場を分析しました。・エグゼクティブ・サマリー・バーキットリンパ腫の治療の世界市場概要・バーキットリンパ腫の治療の製造コスト構成分析・バーキットリンパ腫の治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・バーキットリンパ腫の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・バーキットリンパ腫の治療のセグメント分析（種類別）（ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他）...The global Burkitt Lymphoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Burkitt Lymphoma Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Burkitt Lymphoma Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Burkitt Lymphoma Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

世界の下咽頭癌治療市場 2019年
DATA909X09521 / QYResearch / 2019年11月20日 / ※本調査レポートは、下咽頭癌治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他に、用途別には、外来患者、入院患者にセグメント区分し、下咽頭癌治療の世界市場を分析しました。・エグゼクティブ・サマリー・下咽頭癌治療の世界市場概要・下咽頭癌治療の製造コスト構成分析・下咽頭癌治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・下咽頭癌治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・下咽頭癌治療のセグメント分析（種類別）（ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他）...The global Hypopharyngeal Cancer Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypopharyngeal Cancer Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypopharyngeal Cancer Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypopharyngeal Cancer Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

世界のBRD治療市場 2019年
DATA909X04801 / QYResearch / 2019年11月15日 / ※本調査レポートは、BRD治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗生物質、ワクチンに、用途別には、臨床医学、科学研究、その他にセグメント区分し、BRD治療の世界市場を分析しました。・エグゼクティブ・サマリー・BRD治療の世界市場概要・BRD治療の製造コスト構成分析・BRD治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・BRD治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・BRD治療のセグメント分析（種類別）（抗生物質、ワクチン）...The global BRD Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on BRD Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall BRD Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of BRD Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their BRD Treatment manufacturing...

世界のホジキンリンパ腫治療市場 2019年
DATA909X09212 / QYResearch / 2019年11月20日 / ※本調査レポートは、ホジキンリンパ腫治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Alocrest、ANKプログラム、Azacitidine、BMS-986016、BPX-501、その他に、用途別には、病院、診療所、研究センターにセグメント区分し、ホジキンリンパ腫治療の世界市場を分析しました。・エグゼクティブ・サマリー・ホジキンリンパ腫治療の世界市場概要・ホジキンリンパ腫治療の製造コスト構成分析・ホジキンリンパ腫治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・ホジキンリンパ腫治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・ホジキンリンパ腫治療のセグメント分析（種類別）（Alocrest、ANKプログラム、Azacitidine、BMS-986016、BPX-501、その他）...The global Hodgkin Lymphoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hodgkin Lymphoma Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hodgkin Lymphoma Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hodgkin Lymphoma Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

世界のレイノーズ病治療市場 2019年
DATA909X14126 / QYResearch / 2019年11月20日 / ※本調査レポートは、レイノーズ病治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アセチルシステイン、アルプロスタジル、ELS-140、血管新生物質、ニトログリセリン、その他に、用途別には、病院、診療所、その他にセグメント区分し、レイノーズ病治療の世界市場を分析しました。・エグゼクティブ・サマリー・レイノーズ病治療の世界市場概要・レイノーズ病治療の製造コスト構成分析・レイノーズ病治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・レイノーズ病治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・レイノーズ病治療のセグメント分析（種類別）（アセチルシステイン、アルプロスタジル、ELS-140、血管新生物質、ニトログリセリン、その他）...The global Raynauds Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Raynauds Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Raynauds Disease Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Raynauds Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

◆H&Iグローバルリサーチのお客様（例）◆

世界の市場調査レポート

世界の更年期血管運動症状治療市場 2019年

市場調査レポート・産業資料総合販売サイト MarketReport.jp

市場調査レポート・産業資料 総合販売サイト MarketReport.jp

市場調査レポート・産業資料総合販売サイト MarketReport.jp